Polaris Venture Management Co. V, L.L.C. Buys Pulmatrix Inc

Waltham, MA, based Investment company Polaris Venture Management Co. V, L.L.C. buys Pulmatrix Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Polaris Venture Management Co. V, L.L.C.. As of 2019Q1, Polaris Venture Management Co. V, L.L.C. owns 12 stocks with a total value of $120 million. These are the details of the buys and sells.

For the details of Polaris Venture Management Co. V, L.L.C.'s stock buys and sells, go to https://www.gurufocus.com/guru/polaris+venture+management+co.+v%2C+l.l.c./current-portfolio/portfolio

These are the top 5 holdings of Polaris Venture Management Co. V, L.L.C.
  1. Cardlytics Inc (CDLX) - 2,552,626 shares, 35.54% of the total portfolio.
  2. Fate Therapeutics Inc (FATE) - 1,472,853 shares, 21.65% of the total portfolio. Shares reduced by 19.22%
  3. Kala Pharmaceuticals Inc (KALA) - 1,857,582 shares, 12.85% of the total portfolio.
  4. Neuronetics Inc (STIM) - 742,824 shares, 9.48% of the total portfolio. Shares reduced by 9.94%
  5. X4 Pharmaceuticals Inc (XFOR) - 311,492 shares, 4.54% of the total portfolio.
Added: Pulmatrix Inc (PULM)

Polaris Venture Management Co. V, L.L.C. added to a holding in Pulmatrix Inc by 900.00%. The purchase prices were between $0.77 and $3.28, with an estimated average price of $1.69. The stock is now traded at around $0.99. The impact to a portfolio due to this purchase was 3.44%. The holding were 3,594,381 shares as of .



Here is the complete portfolio of Polaris Venture Management Co. V, L.L.C.. Also check out:

1. Polaris Venture Management Co. V, L.L.C.'s Undervalued Stocks
2. Polaris Venture Management Co. V, L.L.C.'s Top Growth Companies, and
3. Polaris Venture Management Co. V, L.L.C.'s High Yield stocks
4. Stocks that Polaris Venture Management Co. V, L.L.C. keeps buying